Soquelitinib, A Selective Inhibitor of Interleukin-2-Inducible T Cell Kinase (ITK), is Active in Several Murine Models of T Cell-Mediated Inflammatory Disease
Published in 2023 by
Lih-Yun Hsu,
James T. Rosenbaum 
,
Sarah Lindner,
Yannick Allanore,
Anne Cauvet,
Rahul D. Pawar,
Dan Li,
Marcel Van Den Brink,
Richard A. Miller
,
Sarah Lindner,
Yannick Allanore,
Anne Cauvet,
Rahul D. Pawar,
Dan Li,
Marcel Van Den Brink,
Richard A. Miller
